Progress in the mechanism of stem cell derived extracellular vesicles in treatment of early onset ovarian insufficiency
10.11855/j.issn.0577-7402.1106.2023.0227
- VernacularTitle:干细胞源性细胞外囊泡治疗早发性卵巢功能不全的机制研究进展
- Author:
Wen-Zhuo ZENG
1
;
Xin-Yi HUANG
;
Shu-Li XU
;
Xiao-Feng SUN
Author Information
1. 湖南中医药大学医学院,湖南长沙 410208
- Keywords:
premature ovarian insufficient;
extracellular vesicles;
exosomes;
stem cell-derived
- From:
Medical Journal of Chinese People's Liberation Army
2023;48(12):1467-1472
- CountryChina
- Language:Chinese
-
Abstract:
Premature ovarian insufficient(POI)is one of the important causes of infertility in woman of reproductive age.At present,the clinical treatment of POI is limited and the therapeutic effect is not ideal.Extracellular vesicles derived from stem cells have attracted the attention of many researchers at home and abroad as a new cell-free therapy.Many animal experiment study shows that a variety of extracellular vesicles from stem cells carry microRNAs,lncRNAs,lipids,proteins,and other bioactive substances,improve ovarian function,affect granulosa cell proliferation and apoptosis,promote ovarian angiogenesis,and reduce oxidative stress response,thus playing a therapeutic role on POI.This article will review the mechanisms of extracellular vesicles in treatment of POI,and provide evidence for the application of extracellular vesicles in clinical treatment of POI.
